Recent advances in the therapeutic potential of nobiletin against respiratory diseases
Authors:
Open Access
- 1 March 2024
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 128, 155506
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 93 references indexed in Scilit:
- Nobiletin as an inducer of programmed cell death in cancer: a reviewApoptosis, 2022
- Guidelines for the Treatment of Pulmonary Arterial HypertensionLung, 2020
- Lung cancer identification: a review on detection and classificationCancer and Metastasis Reviews, 2020
- Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and VitroInflammation, 2018
- Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesisMolecular Nutrition & Food Research, 2015
- Development of High-Energy Amorphous Solid Dispersion of Nanosized Nobiletin, a Citrus Polymethoxylated Flavone, with Improved Oral BioavailabilityJournal of Pharmaceutical Sciences, 2011
- Nobiletin, a polymethoxylated flavonoid from citrus, shows anti‐angiogenic activity in a zebrafish in vivo model and HUVEC in vitro modelJournal of Cellular Biochemistry, 2011
- Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel Inhibit growth of human lung cancer cells by apoptosisMolecular Nutrition & Food Research, 2009
- Natural Products in Drug Discovery: Present Status and Perspectives2009
- Identification of nobiletin metabolites in mouse urineMolecular Nutrition & Food Research, 2006